Chapter 11: HPV vaccines: Commercial Research & Development

This publication has 15 references indexed in Scilit:

• Immune responses to human papillomavirus
  Vaccine, 2005
• Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant
  Journal of Immune Based Therapies and Vaccines, 2005
• Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination
  Journal of Clinical Virology, 2005
• Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04
  Vaccine, 2004
• A Novel Human Papillomavirus Type 6 Neutralizing Domain Comprising Two Discrete Regions of the Major Capsid Protein L1
  Virology, 2001
• Human Papillomavirus Type 11 (HPV‐11) Neutralizing Antibodies in the Serum and Genital Mucosal Secretions of African Green Monkeys Immunized with HPV‐11 Virus‐like Particles Expressed in Yeast
  The Journal of Infectious Diseases, 1997
• Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization
  Virology, 1996
• Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
  Proceedings of the National Academy of Sciences, 1995
• Titration of HPV-11 Infectivity and Antibody Neutralization Can Be Measured In Vitro
  Journal of Investigative Dermatology, 1995
• Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
  Vaccine, 1995